Target intelligence / Profile preview

Novel transcript, antisense to TSPO

Molecular classification
Other (long non-coding RNA)
01

Overview

This locus encodes a long non-coding RNA (lncRNA) that is transcribed antisense to the TSPO gene. There is no current evidence that this antisense transcript functions as a receptor, enzyme, transporter, or known therapeutic target. Its biological function and significance in disease pathways have not been established. It is distinct from the protein-coding TSPO (translocator protein) gene, which is a well-known mitochondrial protein associated with steroidogenesis, apoptosis, and neurodegenerative diseases, but this antisense lncRNA itself is not a canonical drug target. The entry is a valid gene, but as a non-coding antisense RNA, it is not generally recognized as a therapeutic target or classified in major drug target classes. No specific aliases, roles in disease, known functions, or drug interactions are documented in current databases.

Other names
Novel transcript, antisense to TSPOAntisense to TSPO lncRNAENSG00000303951
02

Biological functions

Unknown
03

Disease associations

Unknown or not established

Beyond the preview

Go deeper on Novel transcript, antisense to TSPO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to TSPO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call